|
1
|
Böckelman C, Engelmann BE, Kaprio T,
Hansen TF and Glimelius B: Risk of recurrence in patients with
colon cancer stage II and III: a systematic review and
meta-analysis of recent literature. Acta Oncol. 54:5–16. 2015.
View Article : Google Scholar
|
|
2
|
Akiyoshi T, Kobunai T and Watanabe T:
Recent approaches to identifying biomarkers for high-risk stage II
colon cancer. Surg Today. 42:1037–1045. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Miska EA: How microRNAs control cell
division, differentiation and death. Curr Opin Genet Dev.
15:563–568. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Cai Y, Yu X, Hu S and Yu J: A brief review
on the mechanisms of miRNA regulation. Genomics Proteomics
Bioinformatics. 7:147–154. 2009. View Article : Google Scholar
|
|
6
|
Ogata-Kawata H, Izumiya M, Kurioka D,
Honma Y, Yamada Y, Furuta K, Gunji T, Ohta H, Okamoto H, Sonoda H,
et al: Circulating exosomal microRNAs as biomarkers of colon
cancer. PLoS One. 9:e929212014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Shivapurkar N, Weiner LM, Marshall JL,
Madhavan S, Deslattes Mays A, Juhl H and Wellstein A: Recurrence of
early stage colon cancer predicted by expression pattern of
circulating microRNAs. PLoS One. 9:e846862014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hwang WL, Jiang JK, Yang SH, Huang TS, Lan
HY, Teng HW, Yang CY, Tsai YP, Lin CH, Wang HW, et al:
MicroRNA-146a directs the symmetric division of Snail-dominant
colorectal cancer stem cells. Nat Cell Biol. 16:268–280. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhao Y, Miao G, Li Y, Isaji T, Gu J, Li J
and Qi R: MicroRNA- 130b suppresses migration and invasion of
colorectal cancer cells through downregulation of integrin β1
[corrected]. PLoS One. 9:e879382014. View Article : Google Scholar
|
|
10
|
Zhang Y, Geng L, Talmon G and Wang J:
MicroRNA-520g confers drug resistance by regulating p21 expression
in colorectal cancer. J Biol Chem. 290:6215–6225. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kurihara H, Maruyama R, Ishiguro K, Kanno
S, Yamamoto I, Ishigami K, Mitsuhashi K, Igarashi H, Ito M, Tanuma
T, et al: The relationship between EZH2 expression and microRNA-31
in colorectal cancer and the role in evolution of the serrated
pathway. Oncotarget. 7:12704–12717. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Uchino K, Takeshita F, Takahashi RU,
Kosaka N, Fujiwara K, Naruoka H, Sonoke S, Yano J, Sasaki H, Nozawa
S, et al: Therapeutic effects of microRNA-582-5p and -3p on the
inhibition of bladder cancer progression. Mol Ther. 21:610–619.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Liu Y, Jiang J, Wang X, Zhai F and Cheng
X: miR-582-5p is upregulated in patients with active tuberculosis
and inhibits apoptosis of monocytes by targeting FOXO1. PLoS One.
8:e783812013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Saal LH, Gruvberger-Saal SK, Persson C,
Lövgren K, Jumppanen M, Staaf J, Jönsson G, Pires MM, Maurer M,
Holm K, et al: Recurrent gross mutations of the PTEN tumor
suppressor gene in breast cancers with deficient DSB repair. Nat
Genet. 40:102–107. 2008. View Article : Google Scholar
|
|
15
|
Di Cristofano A and Pandolfi PP: The
multiple roles of PTEN in tumor suppression. Cell. 100:387–390.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Price TJ, Hardingham JE, Lee CK, Townsend
AR, Wrin JW, Wilson K, Weickhardt A, Simes RJ, Murone C and Tebbutt
NC: Prognostic impact and the relevance of PTEN copy number
alterations in patients with advanced colorectal cancer (CRC)
receiving bevacizumab. Cancer Med. 2:277–285. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lewis BP, Shih IH, Jones-Rhoades MW,
Bartel DP and Burge CB: Prediction of mammalian microRNA targets.
Cell. 115:787–798. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wong N and Wang X: miRDB: an online
resource for microRNA target prediction and functional annotations.
Nucleic Acids Res. 43:D146–152. 2015. View Article : Google Scholar :
|
|
19
|
Han XJ, Yang ZJ, Jiang LP, Wei YF, Liao
MF, Qian Y, Li Y, Huang X, Wang JB, Xin HB, et al: Mitochondrial
dynamics regulates hypoxia-induced migration and antineoplastic
activity of cisplatin in breast cancer cells. Int J Oncol.
46:691–700. 2015.
|
|
20
|
Cheng CJ, Bahal R, Babar IA, Pincus Z,
Barrera F, Liu C, Svoronos A, Braddock DT, Glazer PM, Engelman DM,
et al: MicroRNA silencing for cancer therapy targeted to the tumour
microenvironment. Nature. 518:107–110. 2015. View Article : Google Scholar
|
|
21
|
Garofalo M and Croce CM: Role of microRNAs
in maintaining cancer stem cells. Adv Drug Deliv Rev. 81:53–61.
2015. View Article : Google Scholar :
|
|
22
|
Di Leva G, Garofalo M and Croce CM:
MicroRNAs in cancer. Annu Rev Pathol. 9:287–314. 2014. View Article : Google Scholar :
|
|
23
|
Lim EL, Trinh DL, Scott DW, Chu A,
Krzywinski M, Zhao Y, Robertson AG, Mungall AJ, Schein J, Boyle M,
et al: Comprehensive miRNA sequence analysis reveals survival
differences in diffuse large B-cell lymphoma patients. Genome Biol.
16:182015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yang Y, Xing Y, Liang C, Hu L, Xu F and
Chen Y: Crucial microRNAs and genes of human primary breast cancer
explored by microRNA-mRNA integrated analysis. Tumour Biol.
36:5571–5579. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hata A and Kashima R: Dysregulation of
microRNA biogenesis machinery in cancer. Crit Rev Biochem Mol Biol.
51:121–134. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhang X, Zhang Y, Yang J, Li S and Chen J:
Upregulation of miR-582-5p inhibits cell proliferation, cell cycle
progression and invasion by targeting Rab27a in human colorectal
carcinoma. Cancer Gene Ther. 22:475–480. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Floyd DH, Zhang Y, Dey BK, Kefas B, Breit
H, Marks K, Dutta A, Herold-Mende C, Synowitz M, Glass R, et al:
Novel anti-apoptotic microRNAs 582-5p and 363 promote human
glioblastoma stem cell survival via direct inhibition of caspase 3,
caspase 9, and Bim. PLoS One. 9:e962392014. View Article : Google Scholar
|
|
28
|
Jiang J, Zhang Y, Yu C, Li Z, Pan Y and
Sun C: MicroRNA-492 expression promotes the progression of hepatic
cancer by targeting PTEN. Cancer Cell Int. 14:952014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Peng L, Zhu H, Wang J, Sui H, Zhang H, Jin
C, Li L, Xu T and Miao R: miR-492 is functionally involved in
oxaliplatin resistance in colon cancer cells LS174T via its
regulating the expression of CD147. Mol Cell Biochem. 405:73–79.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wiggins JF, Ruffino L, Kelnar K, Omotola
M, Patrawala L, Brown D and Bader AG: Development of a lung cancer
therapeutic based on the tumor suppressor microRNA-34. Cancer Res.
70:5923–5930. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Shimbo K, Miyaki S, Ishitobi H, Kato Y,
Kubo T, Shimose S and Ochi M: Exosome-formed synthetic microRNA-143
is transferred to osteosarcoma cells and inhibits their migration.
Biochem Biophys Res Commun. 445:381–387. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Tivnan A, Orr WS, Gubala V, Nooney R,
Williams DE, McDonagh C, Prenter S, Harvey H, Domingo-Fernández R,
Bray IM, et al: Inhibition of neuroblastoma tumor growth by
targeted delivery of microRNA-34a using anti-disialoganglioside
GD2 coated nanoparticles. PLoS One. 7:e381292012.
View Article : Google Scholar
|
|
33
|
Wang H, Jiang Y, Peng H, Chen Y, Zhu P and
Huang Y: Recent progress in microRNA delivery for cancer therapy by
non-viral synthetic vectors. Adv Drug Deliv Rev. 81:142–160. 2015.
View Article : Google Scholar
|
|
34
|
Kosaka N, Takeshita F, Yoshioka Y,
Hagiwara K, Katsuda T, Ono M and Ochiya T: Exosomal
tumor-suppressive microRNAs as novel cancer therapy: 'exocure' is
another choice for cancer treatment. Adv Drug Deliv Rev.
65:376–382. 2013. View Article : Google Scholar
|
|
35
|
Guo X, Zhang J, Pang J, He S, Li G, Chong
Y, Li C, Jiao Z, Zhang S and Shao M: MicroRNA-503 represses
epithelial-mesenchymal transition and inhibits metastasis of
osteosarcoma by targeting c-myb. Tumour Biol. 37:9181–9187. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Chun-Zhi Z, Lei H, An-Ling Z, Yan-Chao F,
Xiao Y, Guang-Xiu W, Zhi-Fan J, Pei-Yu P, Qing-Yu Z and Chun-Sheng
K: MicroRNA-221 and microRNA-222 regulate gastric carcinoma cell
proliferation and radioresistance by targeting PTEN. BMC Cancer.
10:3672010. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Ma J, Liu J, Wang Z, Gu X, Fan Y, Zhang W,
Xu L, Zhang J and Cai D: NF-kappaB-dependent microRNA-425
upregulation promotes gastric cancer cell growth by targeting PTEN
upon IL-1β induction. Mol Cancer. 13:402014. View Article : Google Scholar
|
|
38
|
Zhang AX, Lu FQ, Yang YP, Ren XY, Li ZF
and Zhang W: MicroRNA-217 overexpression induces drug resistance
and invasion of breast cancer cells by targeting PTEN signaling.
Cell Biol Int. Jun 24–2015.Epub ahead of print. View Article : Google Scholar
|
|
39
|
Tang JM, He QY, Guo RX and Chang XJ:
Phosphorylated Akt overexpression and loss of PTEN expression in
non-small cell lung cancer confers poor prognosis. Lung Cancer.
51:181–191. 2006. View Article : Google Scholar
|
|
40
|
Feng B, Zhang K, Wang R and Chen L:
Non-small-cell lung cancer and miRNAs: novel biomarkers and
promising tools for treatment. Clin Sci (Lond). 128:619–634. 2015.
View Article : Google Scholar
|
|
41
|
Harris SL and Levine AJ: The p53 pathway:
positive and negative feedback loops. Oncogene. 24:2899–2908. 2005.
View Article : Google Scholar : PubMed/NCBI
|
